Lixte Biotechnology (LIXT) Insider Trading & Ownership $1.27 -0.09 (-6.61%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.27 0.00 (-0.01%) As of 02/21/2025 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lixte Biotechnology (NASDAQ:LIXT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.80%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$75,906.00Number OfInsiders Selling(Last 3 Years)0 Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LIXT Insider Buying and Selling by Quarter Lixte Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/3/2023Der Baan Bastiaan Jeroen VanCEOBuy10,000$2.80$28,000.00 12/15/2022Rene BernardsDirectorBuy1,500$5.10$7,650.00 12/12/2022Rene BernardsDirectorBuy1,000$6.10$6,100.00 11/21/2022Eric FormanCOOBuy145$5.60$812.00 11/21/2022Regina BrownDirectorBuy500$5.80$2,900.00 11/17/2022Eric FormanCOOBuy485$5.40$2,619.00 11/14/2022Rene BernardsDirectorBuy5,250$5.30$27,825.00 (Data available from 1/1/2013 forward) LIXT Insider Trading Activity - Frequently Asked Questions Who is on Lixte Biotechnology's Insider Roster? The list of insiders at Lixte Biotechnology includes Der Baan Bastiaan Jeroen Van, Eric Forman, Regina Brown, and Rene Bernards. Learn more on insiders at LIXT. What percentage of Lixte Biotechnology stock is owned by insiders? 14.80% of Lixte Biotechnology stock is owned by insiders. Learn more on LIXT's insider holdings. Which Lixte Biotechnology insiders have been buying company stock? The following insider purchased LIXT shares in the last 24 months: Der Baan Bastiaan Jeroen Van ($28,000.00). How much insider buying is happening at Lixte Biotechnology? Insiders have purchased a total of 10,000 LIXT shares in the last 24 months for a total of $28,000.00 bought. Lixte Biotechnology Key ExecutivesMr. Bastiaan van der Baan M.Sc. (Age 52)President, CEO & Chairman of the Board of Directors Compensation: $172.78kMr. Robert Neal Weingarten (Age 72)VP & CFO Compensation: $175kMr. Eric J. Forman J.D. (Age 45)VP & COO Compensation: $200kMr. Johannes Henricus Matthias Schellens M.D. (Age 68)Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies BioCardia Insider Transactions BriaCell Therapeutics Insider Transactions Omega Therapeutics Insider Transactions Acurx Pharmaceuticals Insider Transactions Sensei Biotherapeutics Insider Transactions TherapeuticsMD Insider Transactions Flora Growth Insider Transactions Chromocell Therapeutics Insider Transactions Talphera Insider Transactions Kiora Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:LIXT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
